An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for NEOGENOMICS Inc
| Ticker | NEO |
| FIGI | BBG000BKH263 |
| CUSIP | 64049M209 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 250 / 3.6% |
| Percentage held by institutional investors | 100.0% |
About
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia